Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial - Ludolph, A C; Schuster, J; Dorst, J (Lancet Neurol, 2018)